Insulin resistance and hyperlipidemia in women with bipolar disorder

Journal of Psychiatric Research

Volumn 43, Issue 3, 2009, Pages 341-343

  Stemmle, Pascale G ^a   Kenna, Heather A ^a   Wang, Po W ^a   Hill, Shelley J ^a   Ketter, Terence A ^a   Rasgon, Natalie L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; VALPROIC ACID;

ADULT; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL;

ADULT; BIPOLAR DISORDER; BLOOD GLUCOSE; CHOLESTEROL, HDL; FASTING; FEMALE; HUMANS; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; TRIGLYCERIDES;

EID: 57849083014     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.04.003     Document Type: Letter

References (18)

1. Abbasi F., Brown B., Lamendola C., McLaughlin T., and Reaven G. Relationship between obesity, insulin resistance, and coronary heart disease risk. Journal of American College of Cardiology 40 (2002) 937-943
2. Carlson L., Bottiger L., and Ahfeldt P. Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Medica Scandinavica 206 (1979) 351-360
3. Castelli W., Garrison R., Wilson P., Abbott R., Kalonsdian S., Kannel W., et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 256 (1986) 2385-2387
4. Elmslie J., Silverstone J., Mann J., Williams S., and Romans S. Prevalence of overweight and obesity in bipolar patients. Journal of Clinical Psychiatry 61 (2000) 179-184
5. Fagiolini A., Frank E., Houck P., Mallinger A., Swartz H., Buysse D., et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. Journal of Clinical Psychiatry 63 6 (2002) 528-533
6. Fagiolini A., Frank E., Scott J., Turkin S., and Kupfer D. Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians. Bipolar Disorder 7 5 (2005) 424-430
7. Hokanson J., and Austin M. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3 (1996) 213-219
8. Isojärvi J., and Tapanainen J. Valproate, hyperandrogenism, and polycystic ovaries: A report of three cases. Archives of Neurology 57 (2000) 1064-1068
9. Isojärvi J., Rättyä J., and Myllylä V. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Annals of Neurology 43 (1998) 446-451
10. Isojärvi J., Tauboll E., and Pakarinen M. Altered ovarian function and cardiovascular risk factors in valproate treated women. American Journal of Medicine 111 4 (2001) 290-296
11. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine 139 10 (2003) 802-809
12. McLaughlin T., Reaven G., Abbasi F., Lamendola C., Saad M., Waters D., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. American Journal of Cardiology 96 (2005) 399-404
13. Miller G., and Miller N. Plasma high-density-lipoprotein concentration and development of ischemic heart disease. Lancet 1 (1975) 16-19
14. Rasgon N., Altshuler L., Gudeman D., Burt V., Tanavoli S., Hendrick V., et al. Medication status and PCO syndrome in women with bipolar disorder: a preliminary report. Journal of Clinical Psychiatry 61 173-178 (2000)
15. Rasgon N., Carter M., Elman S., Bauer M., Love M., and Korenman S. Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Current Drug Targets Immune Endocrine and Metabolic Disorders 2 (2002) 97-102
16. Rasgon N., Bauer M., Glenn T., Elman S., and Whybrow P. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disorder 5 1 (2003) 48-52
17. Rasgon N., Altshuler L., Fairbanks L., Elman S., Bitran J., Labarca R., et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disorder 7 (2005) 246-259
18. Vainionpää L., Rättyä J., Knip M., Tapanainen J., Pakarinen A., Lanning P., et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology 45 (1999) 444-450